Erratum to: Everolimus Plus Exemestane in Postmenopausal Patients with HR(+) Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis
更正:依维莫司联合依西美坦治疗绝经后HR(+)乳腺癌患者:BOLERO-2最终无进展生存期分析
期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-015-0271-8
Lenchus, Joshua D; Costabel, Ulrich; Bendstrup, Elisabeth; Cottin, Vincent; Dewint, Pieter; Egan, Jim J J; Ferguson, James; Groves, Richard; Hellström, Per M; Kreuter, Michael; Maher, Toby M; Molina-Molina, Maria; Nordlind, Klas; Sarafidis, Alexandre; Vancheri, Carlo; Yardley, Denise A; Noguchi, Shinzaburo; Pritchard, Kathleen I; Burris, Howard A III; Baselga, José; Gnant, Michael; Hortobagyi, Gabriel N; Campone, Mario; Pistilli, Barbara; Piccart, Martine; Melichar, Bohuslav; Petrakova, Katarina; Arena, Francis P; Erdkamp, Frans; Harb, Wael A; Feng, Wentao; Cahana, Ayelet; Taran, Tetiana; Lebwohl, David; Rugo, Hope S